Combined CYP2C9, VKORC1 and CYP4F2 frequencies among Amerindians, Mozambicans and Brazilians.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. VKORC1-1639A allele influences warfarin maintenance dosage among Blacks receiving warfarin anticoagulation: a retrospective cohort study.Future cardiology · 2018
   Article
2. The allele frequency ofResearch in pharmaceutical sciences · 2017
   Article
3. Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population.BMC research notes · 2016
   Article
4. Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain Management.Clinical and translational science · 2015
   Article
5. CYP2C9 allelic variants and frequencies in a pediatric sickle cell disease cohort: implications for NSAIDs pharmacotherapy.Clinical and translational science · 2014
   Article
6. CYP4F2 1347 G > A & GGCX 12970 C > G polymorphisms: frequency in north Indians & their effect on dosing of acenocoumarol oral anticoagulant.The Indian journal of medical research · 2014
   Article
7. Pharmacogenomics of warfarin in populations of African descent.British journal of clinical pharmacology · 2013
   Review
8. Personalized medicine: is it a pharmacogenetic mirage?British journal of clinical pharmacology · 2012
   Review

Corrections and comments

• Comment on
  Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups.2010
• Comment on
  Research highlights. SNPs affecting efficacy and safety of statin therapy.2011

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as